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The phylogenetically conserved nuclear factor I (NFI) gene family encodes site-specific transcription factors
essential for the development of a number of organ systems. We showed previously that Nfia-deficient mice
exhibit agenesis of the corpus callosum and other forebrain defects, whereas Nfic-deficient mice have agenesis
of molar tooth roots and severe incisor defects. Here we show that Nfib-deficient mice possess unique defects
in lung maturation and exhibit callosal agenesis and forebrain defects that are similar to, but more severe than,
those seen in Nfia-deficient animals. In addition, loss of Nfib results in defects in basilar pons formation and
hippocampus development that are not seen in Nfia-deficient mice. Heterozygous Nfib-deficient animals also
exhibit callosal agenesis and delayed lung maturation, indicating haploinsufficiency at the Nfib locus. The
similarity in brain defects in Nfia- and Nfib-deficient animals suggests that these two genes may cooperate in
late fetal forebrain development, while Nfib is essential for late fetal lung maturation and development of the
pons.
Nuclear factor I (NFI) transcription and replication proteins
function both in adenoviral DNA replication (12, 43, 44) and in
the regulation of transcription throughout development (21).
There are four NFI genes in mammals (Nfia, Nfib, Nfic, and
Nfix) and single NFI genes in Drosophila melanogaster, Caeno-
rhabditis elegans, Anopheles spp., and other simple animals (21,
30, 50). No NFI genes have been found in plants, bacteria, or
single-cell eukaryotes. In mammals, NFI proteins function as
homo- or heterodimers and are expressed in complex, over-
lapping patterns during embryogenesis (6, 31). NFI proteins
bind to a dyad-symmetric binding site (TTGGCN5GCCAA)
with high affinity (20, 40), and NFI proteins have been shown
to either activate or repress gene expression depending on the
promoter and cellular context (21, 42). The presence of four
NFI genes in mammals with possibly overlapping functions
makes it a challenge to identify in vivo targets of individual
NFI proteins and the roles of NFI genes in development.
We showed previously that disruption of Nfia causes late
gestation neuroanatomical defects, including agenesis of the
corpus callosum, size reductions in other forebrain commis-
sures, and loss of specific midline glial populations (11, 56). In
contrast, disruption of Nfic results in early postnatal defects in
tooth formation, including the loss of molar roots and aberrant
incisor development (61). In a previous study, insertion of a
lacZ reporter gene into the Nfib locus resulted in defects in
lung maturation but no apparent defects in brain development
(22). Here we report the replacement of the essential exon 2 of
the Nfib gene with a lacZ reporter gene and show that mice
homozygous for our replacement mutation have major neuro-
anatomical defects similar to, but more severe than, those of
Nfia/ mice. These defects include callosal agenesis, aberrant
hippocampus and pons formation, and loss of specific midline
glial populations. In addition, as was seen in the previously
described Nfib insertion mutant, these Nfib-deficient animals
show defects in lung development and die at birth with imma-
ture lungs. The loss of one copy of Nfib results in callosal
agenesis in some animals and reduced lung maturation in all
animals, demonstrating haploinsufficiency at the Nfib locus.
Together, these defects indicate that Nfia and Nfib may func-
tion cooperatively during mouse forebrain development and
that Nfib alone is essential for late gestational lung maturation
and hippocampus and pons development.
MATERIALS AND METHODS
Gene targeting and mouse strains. Genomic clones containing Nfib exons 1
and 2 were isolated from a mouse 129/Sv phage library as described previously
(11, 61). We modified lacZ to encode the simian virus 40 T antigen nuclear
localization signal (NLS) at the -galactosidase (-Gal) N terminus and to
include a phosphoglycerate kinase (PGK) gene poly(A) signal at its 3 end (64),
generating NLS–-Gal–pA. Using a convenient EcoRI site at the 5 end of exon
2 we cloned NLS–-Gal–pA in frame with a 5.65-kb Nfib fragment ending at base
9 of exon 2 to form a translational fusion protein with the product of exon 2 of
Nfib. A PGK-Neo-bGHpA cassette (60) was cloned downstream of the lacZ
fusion cassette, followed by 3 kb of intron 2. The NLS–-Gal–pA and Neo
cassettes replace 700 bp of Nfib, including all but 9 bp of exon 2. A diphtheria
toxin A chain-expressing negative selection cassette (PGK-DTA-bGHpA) was
assembled and cloned downstream of the 3 homologous region in the opposite
transcriptional orientation (67). E14-1 mouse embryonic stem (ES) cells (5 
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106) were electroporated with 5 g of gel-purified 15.2-kb XhoI targeting vector
fragment and then selected in 0.2-mg/ml G418 (GIBCO/BRL) for 6 days. Col-
onies were picked and expanded twice in 96-well plates. Two plates were frozen,
and two were used for DNA isolation and Southern blot analyses.
Correctly targeted ES cells were injected into C57BL/6 blastocysts, and stable
transmission of the targeted allele was assessed by PCR genotyping of the
progeny of founder male chimeras. The targeted (knockout [KO]) allele was
crossed into Black Swiss (Taconic), C57BL/6 (Taconic and Jackson Laborato-
ries), and FVB/N (Jackson Laboratories) strains for analysis. Mice derived from
two independent targeted ES cell clones were analyzed and had indistinguishable
phenotypes. Since some 129 strains of mice have a recessive callosal agenesis
phenotype (35, 36) and since the ES cells used were derived from 129S6 mice, all
brain sections were prepared from mice backcrossed into the Black Swiss (one
generation) or C57BL/6 (more than five generations) strain to avoid the as yet
uncharacterized 129 recessive acallosal-susceptibility locus. The lung morphol-
ogy phenotypes of Nfib mutant animals of the Black Swiss, C57BL/6, and FVB/N
strains were indistinguishable. Each figure legend contains the strain used in the
figure.
PCR genotyping. Postnatal day 10 (P10) to P14 0.5-cm tail tip biopsy samples
were shaken at 55°C overnight in 0.5 ml of tail lysis buffer (100 mM Tris-Cl [pH
8.5], 5 mM EDTA, 200 mM NaCl, 0.2% sodium dodecyl sulfate) including 0.1 mg
of proteinase K/ml. One microliter of the lysate diluted 1:10 in H2O was analyzed
by multiplex PCR (0.5 U of Platinum Taq DNA polymerase [Invitrogen], 1.5 mM
MgCl2, 0.2 mM [each] deoxynucleoside triphosphate, 1 Rediload [Research
Genetics], 1 PCR buffer [Invitrogen; 10 mM Tris-Cl {pH 8.3}, 50 mM KCl,
0.02 mg of bovine serum albumin/ml], five primers at 0.2 M each). Primers were
Nfib specific (a and b), lacZ specific (c), or mouse Y chromosome specific (SRY-1
and -2); sequences are as follows: a, 5-GCTGAGTTGGGAGATTGTGTC-3;
b, 5-TTCTGCTTGATTTCGGGCTTC-3; c, 5-CATCGTAACCGTGCATCT
GCC-3; SRY-1, 5-AACAACTGGGCTTTGCACATTG-3; SRY-2, 5-GTTTA
TCAGGGTTTCTCTCTAGC-3). PCR products were resolved on 2.0% agarose
gels and visualized with ethidium bromide.
PCR and QPCR transcript analysis. Total RNA was isolated with TRIzol
reagent (Invitrogen), and cDNA was generated from 2 to 5 g of RNA with
Superscript II reverse transcriptase (Invitrogen) and random primers as recom-
mended by the manufacturer. Nfib transcripts were analyzed by PCR with an
exon 1-based sense primer (5-GATCGGCCTCACGGGCCGATGATGTATT
CTCCCATCTG-3) and an exon 4-based antisense primer (5-CTCTGATACA
TTGAAGACTCCG-3), and products were resolved on a 2.5% agarose gel.
Transcript levels of all genes shown were quantified by quantitative PCR
(QPCR) with a Bio-Rad iCycler real-time PCR machine and gene-specific prim-
ers that span multiple exons as described previously (61). Primer sequences for
the genes quantified are available upon request.
Tissue preparation and lacZ detection. Embryos were harvested at various
times after detection of a coital plug. For total lung DNA analysis, either the
dissected left lobe (embryonic day 18.5 [E18.5]) or the whole lung (E15.5) was
harvested into 1 ml of 2 M NaCl–2 mM EDTA in phosphate-buffered saline
(PBS) and sonicated on ice, and DNA content was assayed fluorimetrically as
described previously (32) with a 96-well plate fluorimeter and purified calf
thymus DNA as a standard. Whole thoraces were immersed in cold 4% para-
formaldehyde (PFA) overnight, washed in PBS, dehydrated in ethanol, embed-
ded in paraffin, and transversely sectioned at 5 m for hematoxylin and eosin
(H&E) staining and immunohistochemistry.
-Gal staining was performed on cryostat sections of frozen fixed tissues.
Lungs were fixed in PBS containing 0.2% glutaraldehyde, 5 mM EGTA (pH 7.3),
and 0.1 M MgCl2 for 3 h on ice and rinsed three times for 15 min with cold PBS.
Fixed tissues were cryoprotected overnight in cold 30% sucrose in 1 PBS and
then embedded in OCT embedding medium and snap-frozen on dry ice. Cryostat
sections of frozen tissue (10 m) were loaded onto polylysine-coated slides and
allowed to dry at room temperature for 2 h and incubated in -Gal solution (5
mM potassium ferricyanide, 5 mM potassium ferrocyanide, 1 mg of X-Gal
[5-bromo-4-chloro-3-indolyl--D-galactopyranoside]) in buffer (100 mM sodium
phosphate [pH 7.3], 2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40) at
room temperature for 6 h. Stained sections were washed three times in PBS and
then postfixed in distilled water containing 2% glutaraldehyde, 2% PFA, and 0.1
M sodium cacodylate for 1 h at 4°C. The slides were rinsed in three changes of
cold PBS for 10 min each, cleared in distilled water for 5 min, and then coun-
terstained with 0.1% nuclear fast red in 5% aluminum sulfate for 2 min, washed
in running water, dehydrated, and topped with coverslips for analysis.
For whole-mount staining fixed lungs were washed and immediately incubated
in -Gal solution at room temperature overnight without cryoprotection. Stained
lung lobes were washed three times with PBS and postfixed as described above,
and washed left lobes were photographed through a dissecting microscope.
Brain sectioning and staining. Brains were perfused with 4% PFA, fixed
overnight in 4% PFA, and stored in PBS until use. Brains were blocked in 3%
agar and cut at 40 to 50 m on a vibratome (Leica, Deerfield, Ill.). The sections
were counterstained with 2% Mayer’s hematoxylin (Sigma Chemical Co.) for 6
min, or alternatively with 1% thionin, rinsed, dehydrated, and mounted for
analysis.
Immunohistochemistry. All procedures were performed at room temperature.
Brain sections were washed three times in PBS and blocked in a solution of 2%
(vol/vol) serum and 0.2% (vol/vol) Triton X-100 (Sigma) in PBS for 2 h. Normal
goat serum (S-1000; Vector Laboratories, Burlingame, Calif.) or normal donkey
serum (017-000-121; Jackson ImmunoResearch Laboratories, West Grove, Pa.)
was used as the blocking agent. The sections were incubated with the primary
antibody, rabbit anti-glial fibrillary acidic protein (GFAP; 1:30,000; Z0334; Dako,
Glostrup, Denmark) or rat anti-L1 (1:5,000; MAB5272; Chemicon, Temecula,
Calif.), overnight. Sections were then washed three times in PBS and incubated
with the biotinylated secondary antibody (biotinylated goat anti-rabbit secondary
antibody [1:500; Vector Laboratories] or biotinylated donkey anti-rat secondary
antibody [1:500; Jackson ImmunoResearch Laboratories]) for 2 h. After three
washes in PBS, sections were incubated in avidin-biotin solution (1:500; Vector
Laboratories) for 1 h, followed by three washes in PBS. Sections were then
immersed in a nickel–3,3-diaminobenzidine (DAB; D-5905; Sigma)–chromogen
solution (2.5% nickel sulfate and 0.02% DAB in 0.175 M sodium acetate)
activated with 0.01% (vol/vol) H2O2 until a dark purple-black precipitate formed.
Sections were washed in PBS, mounted, and placed on coverslips in DPX mount-
ing medium (Electron Microscopy Services). Labeling was analyzed with an
upright light microscope (Leica). Images were made with a PowerPhase digital
camera (PhaseOne, Copenhagen, Denmark) directly into Adobe Photoshop
software.
Immunohistochemistry for  smooth muscle actin (SMA) was performed
essentially as described previously (41). The smooth muscle differentiation
marker SMA was detected with mouse monoclonal anti-SMA 1A4 (1:20,000;
Sigma). Staining was performed with the Mouse on Mouse kit (Vector Labora-
tories). Biotinylated secondary antibodies were used with a nickel-enhanced
DAB protocol essentially as described for the brain except that slides were
counterstained with nuclear fast red.
RESULTS
Nfib gene targeting and confirmation of Nfib null allele. We
constructed a replacement-type targeting vector by replacing
the most 3 523 bp of exon 2 and the first 177 bp of intron 2
with a translational-fusion -Gal reporter gene and a neomycin
resistance gene (lacZ and Neo, respectively, in Fig. 1A). Since
exon 2 encodes both the DNA-binding and dimerization activ-
ities of NFI, homologous recombination of the native gene and
the targeting vector should generate a null allele. SacI digests
of targeted ES cell genomic DNA analyzed with a DNA probe
that maps external to the targeted region generated 8.2-kb
targeted-allele and 22.7-kb native-allele fragments (Fig. 1A) in
heterozygous targeted ES cells. A Southern blot screen of 80
G418-resistant ES clones identified 6 clones harboring a single
targeted mutation, and a composite of the results of the screen
is shown (Fig. 1B). Further Southern blot analyses using Neo-
and lacZ-specific probes showed that Nfib-targeted clones har-
bored no other vector integrations. PCR analyses confirmed
homologous recombination of the 3 flanking region (data not
shown).
We injected two ES clones heterozygous for the targeted
Nfib mutation (Nfib/) into C57BL/6 mouse blastocysts to
generate chimeras. Male chimeras of one ES clone were
crossed to Black Swiss, 129S6, FVB/N, and C57BL/6 strains,
and genomic DNA from tail biopsy samples of the progeny was
screened by PCR for the mutated allele. Both ES clones trans-
mitted the mutant allele into the germ line, and the phenotypes
of mice derived from the two ES clones were indistinguishable.
To confirm that the targeted Nfib allele was null, we analyzed
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brain, liver, and lung Nfib transcripts isolated from E17.5 lit-
termates of each Nfib genotype. Total RNA was reverse tran-
scribed, and the cDNA then used as the template in PCRs with
Nfib exon 1-specific (forward) and exon 4-specific (reverse)
primers (Fig. 1C). The major product generated from wild-
type (WT; Nfib/) and heterozygote (Nfib/) brain, liver,
and lung cDNA corresponds to a predicted 684-bp product
that includes exon 2 (532 bp), exon 3 (54 bp), and parts of
exons 1 and 4 (Fig. 1C, lanes / and /). However, no
such product was generated from Nfib homozygous mutant
(Nfib/) brain, liver, and lung cDNA (Fig. 1C, lanes /). A
much less abundant product having a migration corresponding
to that of a predicted 152-bp amplicon was generated only
from Nfib/ and Nfib/ brain cDNA. This product likely
represents an Nfib transcript containing exon 1 spliced directly
to exon 3, therefore lacking exon 2. Because exon 1 ends at
codon base 3 and exon 3 begins at codon base 2, such an
aberrantly spliced Nfib transcript would encode a 35-amino-
acid missense polypeptide that terminates at a TAG codon in
exon 4. These data indicate that replacement of all but 3
residues encoded by exon 2 with the -Gal fusion protein
generates a null allele of Nfib.
Lung maturation defects in Nfib-deficient mice. A previous
study showed that mice with an insertion of a lacZ translational
fusion gene into the same EcoRI site in exon 2 of Nfib targeted
here exhibited defects in lung maturation (22). We therefore
examined lung development in our Nfib-null mice. Mouse lung
maturation occurs relatively late in gestation, with final prena-
tal maturation (sacculation) occurring from E16.5 to P3 (10).
Histological examination of lungs in E17.5 Nfib-deficient mice
showed that lungs from Nfib/ mice were severely defective in
maturation, while those from Nfib/ animals had a clear de-
velopmental delay in maturation. WT lungs at E17.5 were well
sacculated (Fig. 2A), while lungs from Nfib/ mice had
FIG. 1. Disruption of Nfib gene and generation of null allele. (A) Nfib targeting vector (top) generated by replacement of most of exon 2 with
the coding sequence for an NLS–-Gal translational fusion protein and a PGK-neo selection cassette. Correct targeting of the Nfib locus causes
loss of a 22.68-kb SacI fragment and gain of an 8-kb SacI fragment (arrows) on screening with the indicated probe. (B) Detection of targeted ES
clones by Southern blotting. Genomic DNA was digested with SacI, analyzed on a 0.8% agarose gel, transferred to a nylon membrane, and
hybridized with the 32P-labeled probe fragment indicated in panel A. The WT allele yields an 23-kb band, while the targeted allele shows an
8-kb band. Lanes 1, 2, and 6 contain both WT and targeted alleles. (C) Loss of full-length Nfib transcripts from brains, livers, and lungs of Nfib/
mice. RNA from the indicated tissues of WT, Nfib/, and Nfib/ mice was isolated and reverse transcribed, and the cDNA was analyzed by PCR
with the exon 1 and exon 4 primers described in Materials and Methods. PCR products were analyzed on 2.0% agarose gels, and three products
were detected, a major 684-bp band containing exons 1 to 4 seen in cDNA from WT and Nfib/ mice and a much weaker 152-bp band lacking
exon 2 seen in cDNA from Nfib/ and Nfib/ mice. Another low-abundance product, migrating at approximately 450 bp, was generated from
WT and Nfib/ cDNA but not from Nfib/ cDNA. This product may represent aberrantly spliced Nfib transcripts. Lane Mr, molecular weight
markers.
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smaller saccules (Fig. 2B) and lungs of Nfib/ mice com-
pletely lacked saccules (Fig. 2C). The morphology of the E17.5
Nfib/ lungs resembled that of less-mature WT E15.5 lungs
(Fig. 2, compare panels C and D). To assess the approximate
time in development at which maturation was arrested, we
examined the morphology of E15.5 WT, Nfib/, and Nfib/
lungs (Fig. 2D to F, respectively). Unlike the case at E17.5, at
E15.5 the WT and mutant lungs had similar morphologies with
dense mesenchyme and no saccules. In addition, levels of
smooth muscle actin expression around the bronchioles (Fig.
2D to F) and vessels (Fig. 2D and F) in WT and mutant mice
were similar. These data indicate that lung development in
Nfib/ mice appears arrested between E15.5 and E16.5 at the
late-pseudoglandular-to-early-canalicular stage of develop-
ment and that Nfib/ mice have a less severe phenotype of
delayed lung maturation.
Perinatal lethality in Nfib-deficient mice. The difference in
severity of the lung maturation defects between Nfib/ and
Nfib/ animals was confirmed by the finding that no Nfib/
animals survived for 24 h after birth (Table 1; 10 litters, 0 of 23
Nfib/ animals alive at day 1), while 60% of the predicted
number of Nfib/ animals survived (34 of 58 predicted
Nfib/ animals). The lethality appears to be perinatal since
the genotypes of E17.5 to E18.5 embryos were present at
nearly the expected Mendelian frequency of 1:2:1 (66 Nfib/
mice, 115 Nfib/ mice, and 70 Nfib/ mice; 31 litters). Com-
pared to Nfib/ animals in the same litters, only 55% of
Nfib/ animals in the C57BL/6 strain survived to genotyping,
suggesting that the delay in lung maturation in Nfib/ animals
reduces early postnatal survival in this strain (Table 2; 70
Nfib/ mice survived to day 14 versus 124 Nfib/ mice; 26
litters). Surprisingly, little or no loss of heterozygotes was seen
during backcrossing to the FVB/N strain, indicating that this
reduction in heterozygote survival is strain specific (Table 2; 83
Nfib/ mice versus 75 Nfib/ mice survived to day 14; 17
litters). Histological evaluation of heterozygote E18.5 lungs
showed that delays in sacculation were indistinguishable
among the strains. Whether this difference in survival of Nfib-
deficient heterozygotes among strains is dependent on modi-
fier genes and/or maternal rearing differences remains to be
determined. These data strongly support a model for haploin-
sufficiency at the Nfib locus.
Changes in gross morphology, DNA content, and epithelial
differentiation markers in lungs of Nfib/ mice. A previous
report on the insertion of a lacZ transgene into exon 2 of Nfib
FIG. 2. Decreased lung maturation in Nfib/ and Nfib/ mice. Transverse sections of E17.5 lungs (A to C) were stained with H&E, and E15.5
lungs (D to F) were stained with a monoclonal antibody against a smooth muscle actin (SMA) and counterstained with nuclear fast red. E17.5
Nfib/ lungs (A) show normal sacculation (open areas that produce a “Swiss cheese” appearance), while Nfib/ lungs (B) have reduced
sacculation and Nfib/ lungs (C) show essentially no sacculation. E15.5 lungs of all three genotypes (Nfib/ [D], Nfib/ [E], and Nfib/ [F])
showed similar cellular morphologies and SMA staining in smooth muscle surrounding bronchioles (arrows) and vessels (arrowheads). Mice were
in the Black Swiss (A to C) and FVB/N (D to F) backgrounds.
TABLE 1. Lethality in Nfib-deficient animalsa
Status of animal
on day 1
No. of animals of genotype:
/ / /
Live 0 34 29
Dead 23 2 0
Expected 29 58 29
a Heterozygous Nfib/ mixed Black Swiss/129S6 strain animals were bred,
and the numbers of animals of different genotypes that were born and survived
to day 1 after birth are shown. The expected numbers for heterozygote Nfib/
and homozygote Nfib/ animals are twice and equal to, respectively, the num-
ber of Nfib/ animals obtained. No Nfib/ animals survived to day 1 after birth
from 10 litters. The apparent reduction in Nfib/ animals may be due to
cannibalism of some dead pups by the mothers.
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described the lungs of the resulting mice as hypoplastic (22).
We dissected lungs from our E15.5 and E18.5 WT and Nfib-
deficient embryos to assess their gross morphology. The gross
morphologies of WT and Nfib-deficient lungs were almost in-
distinguishable at E15.5 (Fig. 3A; left lobes are shown for
comparison). Upon close inspection, slight indentations were
detected on the surfaces of Nfib/ lungs (Fig. 3A). At later
times in gestation these indentations became more pro-
nounced and obvious surface clefts or crevices were seen in all
Nfib/ lungs examined (Fig. 3B and C). Despite the presence
of these defects in the pleural surface, Nfib/ lungs were not
obviously hypoplastic.
To determine whether there was overall cell loss (hypopla-
sia) in the Nfib/ lungs, we assessed the left lung DNA con-
tents and total body weights of E18.5 embryos (Table 3). While
the total body weights of WT, Nfib/, and Nfib/ animals
were similar, there was a substantial increase in the total DNA
in the lungs of Nfib/ animals, resulting in an increased ratio
of DNA content to total body weight for these animals (Table
3; Nfib/ versus Nfib/). Thus while differentiation of type I
and II epithelial cells appears defective in the Nfib/ lungs
(see below), there is an apparent increase in cell number in the
Nfib/ lungs. These data indicate that, rather than hypoplasia
or cell loss in the Nfib/ lungs, there is instead an increase in
DNA content, suggesting a defect in either the turning off of
cell proliferation or in apoptosis during lung maturation (62).
We also measured proliferating cell nuclear antigen (PCNA)
levels in WT and Nfib mutant lungs to assess overall levels of
cell proliferation. PCNA transcripts were increased approxi-
mately fourfold at E18.5 in Nfib/ versus Nfib/ lungs, sug-
gesting that higher levels of proliferation occurred in the mu-
tant lungs (Table 4). This apparent increase in proliferation is
consistent with the thickened mesenchyme and increased DNA
content in Nfib/ lungs and may reflect a failure of the normal
reduction in mesenchymal proliferation seen during lung mat-
uration (62). As an initial screen for signaling molecules that
may influence cell proliferation during lung maturation, we
used QPCR to assess the levels of Fgf-10, Fgf-7, and Midkine
transcripts in WT and Nfib/ lungs. Fibroblast growth factor
signaling is essential for early lung development, and loss of
Fgf-10 results in a lack of branching morphogenesis (53). While
there was an2-fold increase in Fgf-10 levels and no change in
Fgf-7 levels in E18.5 Nfib/ lungs relative to Nfib/ lungs,
there was an 11-fold increase in Midkine expression in the
mutant lungs (Table 4). Since increased Midkine levels have
been associated with the decreased lung maturation seen in
glucocorticoid receptor-deficient mice (28) and with lung vas-
cular remodeling after hypoxia (48), it will be important to
FIG. 3. Gross morphological changes in Nfib/ lungs. Dissected
left lobes are shown unstained at E15.5 (A), whole mount stained for
-Gal at E18.5 (B; gal), and H&E stained in transverse section at
E18.5 (B; H&E). Although there is no gross change in overall size and
shape, minor surface indentations seen in E15.5 lungs appear more
striking as deep clefts or ruffles at E18.5. lacZ expression is detected in
Nfib/ lungs but not Nfib/ lungs (B). Arrows, surface indentations
and clefts.
TABLE 2. Loss of Nfib/ animals during backcrossing of
heterozygous Nfib/ animals to the C57BL/6 but not the
FVB/N straina
Strain
No. of live animals of genotype:
/ /
Observed Expected Observed Expected
C57BL/6 70 124 124 124
FVB/N 83 75 75 75
a Heterozygous Nfib/ males were bred with WT C57BL/6 and FVB/N fe-
males, and the numbers of Nfib/ and Nfib/ animals alive at day 14 after birth
were recorded. Twenty-six and 17 litters were examined during 5 backcross
generations into C57BL/6 and FVB/N, respectively. The expected numbers are
derived from the number of Nfib/ progeny obtained.
TABLE 3. Total body weights and DNA contents of the left lunga
Genotype No. ofpups
Total body
wt (g)
Left lung DNA/total
body wt (g/g)
Nfib/ 6 1.18 	 0.065 38.6 	 3.93
Nfib/ 12 1.21 	 0.124 51.9 	 5.08
Nfib/ 5 1.38 	 0.083 73.1 	 10.47
a Data are means 	 standard deviations.
TABLE 4. Transcript levels in Nfib/ and Nfib/ lungs relative
to those in Nfib/ lungsa
Gene
Relative level in E18.5 lungs of:
Nfib/ mice Nfib/ mice
PCNA 1.3 	 0.1 3.8 	 0.5
Fgf-10 1.0 	 0.1 2.2 	 0.8
Fgf-7 1.1 	 0.4 0.7 	 0.2
Midkine 2.1 	 0.6 11.0 	 2.1
SP-A 0.8 	 0.2 0.4 	 0.1
SP-B 0.5 	 0.2 0.2 	 0.1
SP-C 0.7 	 0.2 0.5 	 0.1
SP-D 0.5 	 0.1 0.1 	 0.04
Aqp-1 0.6 	 0.1 0.3 	 0.1
ENaC 0.6 	 0.1 0.3 	 0.1
a Transcript levels, measured by QPCR and normalized to 2-microglobulin
levels in each sample, were divided by those found in Nfib/ littermates and
expressed as means 	 standard deviations. At least two independent litters were
used for analysis of each gene, with multiple animals of each genotype.
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assess Midkine’s role in the apparent increase in mesenchymal
cell density in Nfib/ lungs.
To determine if morphological immaturity corresponded
with reduced expression of maturation-associated genes, we
examined the transcript levels at E18.5 of a number of genes
whose expression is known to increase from E16.5 to E18.5 in
normal mouse lung development. Lung maturation from E16.5
to E18.5 is characterized by large increases in markers of type
II epithelial and type I squamous epithelial cell differentiation
(65). Using QPCR we showed that a number of type II cell
markers, including surfactant protein A (SP-A), SP-B, SP-C,
and SP-D, are greatly reduced in Nfib/ lungs and partially
reduced in Nfib/ lungs relative to WT lungs at E18.5 (Table
4). Also, type I cell markers Aquaporin-1 (Aqp-1) and the
epithelial sodium channel gene (ENaC) were strongly reduced
in Nfib/ lungs and partially reduced in Nfib/ lungs (Table
4). These data indicate that loss of Nfib results in a significant
reduction in expression of terminal differentiation markers of
type II and type I cells, suggesting that Nfib is essential for the
normal differentiation of these cells.
Nfib::lacZ expression during lung development. Lung devel-
opment requires many reciprocal epithelial-mesenchymal in-
ductions (see references 25 and 54 for reviews). While our
previous in situ data showed that Nfib is highly expressed in the
developing lung (6), the cellular expression pattern was not
determined. To identify the specific cell compartments where
Nfib is expressed during lung development, we stained lungs of
mice heterozygous for the Nfib::lacZ allele for -Gal activity.
Nfib::lacZ was uniformly expressed at high levels throughout
the mesenchyme at E14.5, whereas weaker expression was de-
tected in a few scattered epithelial cells at this time (Fig. 4A).
Nfib::lacZ was expressed at similar levels in most epithelial and
mesenchymal cells at E16.5, with increased expression in
smooth muscle (Fig. 4B). At E18.5, Nfib::lacZ was expressed in
a subset of both proximal and distal epithelial cells, while
mesenchymal expression was decreased but still present in the
smooth muscle (Fig. 4C and D). LacZ staining was not de-
tected in WT E18.5 lung (Fig. 4E). In adult lung Nfib::lacZ was
expressed primarily in the bronchiolar epithelium and type II
cells (Fig. 4F). Preliminary immunohistochemistry with Nfib-
specific antibodies supports this pattern for endogenous Nfib in
WT mice (C. Bachurski, unpublished data). These data indi-
cate that Nfib could play essential roles in either the lung
mesenchyme or epithelium during late prenatal lung matura-
tion.
Nfib/ mice display agenesis of the corpus callosum, en-
largement of the lateral ventricles, and malformation of mid-
line glial populations. We showed previously that loss of Nfia
resulted in major neurological defects, including agenesis of
the corpus callosum and defects in other forebrain commis-
sures (11, 56). Although the previous study of a lacZ insertion
into the Nfib locus reported no effects on brain development
(22), we found multiple profound defects in brain development
in our Nfib/ mice. As seen previously in our Nfia/ mice
(56), Nfib/ mice exhibit agenesis of the corpus callosum on
both mixed Black Swiss/129S6 (Fig. 5A to C) (n 
 4) and
C57BL/6 (Fig. 5D to I) (n 
 3) backgrounds. This was evident
with hematoxylin staining (Fig. 5A to F) and was confirmed by
L1 cell adhesion molecule (CAM) immunohistochemistry,
which labels axonal tracts (Fig. 5G to I). On the mixed Black
Swiss background, most heterozygous Nfib/ animals also
displayed a callosal phenotype (n 
 8 of 11), with the forma-
tion of Probst bundles at the midline (n 
 11 of 11; Fig. 5B).
However this phenotype in heterozygotes was less penetrant (n

 1 of 7) after backcrossing the allele onto a C57BL/6 back-
ground (Fig. 5E).
Surviving postnatal Nfia/ mice on a mixed Black Swiss-
129S6-C57BL/6 background exhibit severe hydrocephalus (11).
Although Nfib/ mice die at birth, precluding analysis of
postnatal hydrocephalus, embryonic Nfib/ mice have larger
ventricles (Fig. 5C and F) than their WT and heterozygote
littermates on both mixed Black Swiss and C57BL/6 back-
grounds. These data suggest that both Nfib and Nfia may in-
fluence cerebrospinal fluid transport and/or production in the
brain.
Midline glial populations are important for the formation of
the corpus callosum, as they secrete guidance factors, such as
Slit2, that guide callosal axons both before and after they cross
the midline (58, 59). Figure 6 shows an immunohistochemical
analysis of GFAP expression. Three midline glial populations
are evident in WT animals: the glial wedge (GW), glia within
the indusium griseum (IGG), and the midline zipper glia
(MZG; Fig. 6D) (57). Nfib/ mice showed a reduction in
GFAP expression at the midline, which likely reflects a loss or
reduction in these glial populations. This phenotype is similar
to that observed in Nfia/ mice (56). Nfib/ mice display a
complete absence of GFAP labeling in the regions of both the
IGG and the MZG (Fig. 6F and L). Furthermore, although a
few glial cells were present, the GW was greatly reduced in the
Nfib/ animals (Fig. 6F and L). Since there are NFI binding
sites in the GFAP gene promoter, these results, together with
our results for Nfia/ mice (56), suggest that NFI genes may
regulate both GFAP expression and glial development. Fur-
ther evidence for such regulation is that Nfib/ mice on a
C57BL/6 background display lower levels of expression of
GFAP than their Nfib/ littermates (compare Fig. 6K and J).
Although all three midline glial populations were present in
Nfib/animals on both the Black Swiss and C57BL/6 back-
ground, the IGG appeared disorganized on the Black Swiss
background, probably due to the formation of Probst bundles
at the midline (Fig. 6E).
We showed previously that GFAP expression is decreased in
Nfia/ brains relative to WT brains (11). Since we observed a
decrease in GFAP-positive midline glial cells in Nfib/ brains,
we examined GFAP transcript levels in Nfib/ whole brains.
Although GFAP transcript levels were reduced 5-fold in
Nfib/ brains relative to WT, this decrease is less than the
10-fold decrease seen in Nfia/ brains (Table 5). While
examining the expression of genes proposed to influence fore-
brain development in Nfia KO mice, we noted that Tbr2 tran-
script levels were increased 1.9-fold in Nfia/ brains relative
to Nfia/ brains (Table 5). However, Nfib/ brains had no
higher levels of Tbr2 transcripts than did Nfib/ brains (Table
5). Thus, while the neuroanatomical defects in the Nfib/
brains appear more severe than those of Nfia/ brains, the
changes in GFAP and Tbr2 expression in Nfib/ brains are
less than those observed in Nfia/ animals. In addition, there
were no apparent changes in the levels of transcripts for some
other genes that have been proposed to play a role in callosum
formation and forebrain development, including Slit2, Robo1
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to -3, DCC, Netrin, and others (Table 5). Thus the reduction in
GFAP transcripts is the only consistent change in gene expres-
sion so far detected in Nfib/ brains and is likely due at least
in part to the observed loss of GFAP expression from specific
midline glial cells.
Nfib regulates development of the hippocampus and the
basilar pons. Nfib/ mice also displayed severe disruptions in
the formation of the hippocampus (Fig. 7). At E17.5 the den-
tate gyrus was absent (Fig. 7A, C, and F) and the entire CA3
region (Fig. 7A) appeared to be absent or severely reduced
(Fig. 7C and F). The fimbria, which contains the efferent pro-
jections from the hippocampus, was also greatly reduced (com-
pare Fig. 7C with A and B and F with D and E). This pheno-
type was evident on both the Black Swiss background and the
C57BL/6 background, but the losses appeared to be more
severe on the C57BL/6 background. To ask whether the de-
fects were due to degeneration of these areas or, conversely, to
a delay in development, we examined the hippocampal primor-
FIG. 4. Expression of -Gal from the Nfib-lacZ allele in Nfib/ lungs. Frozen sections of lungs of E14.5 (A), E16.5 (B), E18.5 (C and D), and
adult Nfib/ (F) or E18.5 Nfib/ (E) mice were stained for -Gal activity. -Gal expression was predominantly mesenchymal at E14.5. Smooth
muscle was strongly positive from E16.5 to E18.5, with reduced staining in adult lung (arrows). Expression decreased in the mesenchyme and
increased in both proximal and distal epithelial cells from E16.5 through E18.5. -Gal expression was mainly in a subset of the bronchiolar
epithelium and type II cells in adult lung. Br, bronchiole; V, vessel; arrows, smooth muscle; arrowheads, epithelium. The scale bar (E) applies to
all panels. Mice were in the FVB/N background.
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dium at E15.5 (Fig. 7G to I). Even at E15.5 defects in hip-
pocampal development were present. The entire hippocampal
primordium, including the fimbria, was reduced in size. These
data suggest that Nfib may regulate hippocampal cell prolifer-
ation and, since the CA1 region was less affected, possibly the
regionalization of the hippocampus into different subfields.
Previous studies showed that Nfib, Nfia, and Nfix are highly
expressed in the basilar pons (6, 16), a hindbrain nucleus that
provides significant mossy fiber input to the cerebellum. To
investigate the role of Nfib in the development of the basilar
pons, we examined Nfib/ hindbrains at E16.5 to E18.5 on
C57BL/6 and Black Swiss backgrounds. The basilar pons is well
formed at E18.5 in WT (n 
 3) and heterozygote (n 
 5)
animals (Fig. 8A and B). However, the basilar pons was virtu-
ally absent in Nfib/ brains (n 
 4), with only a small cap of
cells remaining (Fig. 8C). The pontine phenotype was evident
from E16.5 to E18.5 in both Black Swiss (Nfib/, n 
 3;
Nfib/, n 
 5; Nfib/, n 
 4) and C57BL/6 backgrounds.
The rest of the hindbrain, including another precerebellar nu-
cleus, the inferior olive, appears normal (Fig. 8B and C). In
addition, the cerebellum is present and the normal lamination
can be identified in the mutant. However, although foliation
begins at this age in WT and heterozygous mice, the cerebel-
lum appears unfoliated in Nfib/ mice (Fig. 8C versus A). It
will be of interest to determine whether this apparent de-
creased foliation reflects changes in cerebellar cell prolifera-
tion or differentiation.
Expression of the other three Nfi genes in Nfib-deficient
animals. To determine if loss of Nfib affected the expression
levels of the other three Nfi genes, we assessed Nfi transcript
levels in the lungs and brains of E18.5 WT and Nfib/ ani-
mals. There were5.1, 3.3, and 2.8-fold increases in Nfia, Nfic,
and Nfix expression, respectively, in Nfib/ lungs relative to
WT lungs (Table 6). Thus, of the three NFI genes remaining in
Nfib/ mice, the Nfia gene has the largest increase in expres-
sion in lung. In E18.5 whole brain, there was a 2.2-fold increase
in Nfia expression but no significant change in Nfic or Nfix
expression (Table 6). These data indicate that there were
greater changes in the expression of the remaining Nfi genes in
the lungs of Nfib-deficient animals than in the brains of these
animals and that Nfia exhibited the greatest changes in both
tissues. The significance of these changes and their relationship
to the phenotypes seen in the tissues are being examined.
DISCUSSION
By replacing exon 2 of Nfib with a lacZ translational fusion
construct (Fig. 1) we have shown that Nfib is essential for
perinatal survival (Tables 1 and 2), late fetal lung maturation
(Fig. 2 and 3; Tables 3 and 4), and brain development (Fig. 5
to 8 and Table 5). Loss of Nfib results in apparent arrest of
fetal lung maturation at the late-pseudoglandular or early-
canalicular stage, as indicated by both morphology (Fig. 2) and
reduced expression of several late lung differentiation markers
(Table 4). In addition, severe defects in development of the
corpus callosum (Fig. 5), specific midline glial populations
(Fig. 6), the hippocampus (Fig. 7), and the pons (Fig. 8) show
that Nfib is essential for the proper development of both fore-
brain and hindbrain structures. Since our previous studies in-
dicated that loss of Nfia resulted in callosal agenesis and loss of
FIG. 5. Agenesis of the corpus callosum in Nfib/ mice. Coronal 50-m vibratome sections from E17.5 Nfib brains on either a Black Swiss (A
to C) or C57BL/6 (D to F) background were mounted and stained with hematoxylin (A to F) or stained free-floating with an antibody against L1
CAM (G to I). Arrows in each panel indicate the presence or absence of the corpus callosum; arrowheads (G to I) indicate the presence of the
fornix. Probst bundles were evident in Nfib/ mice on a mixed Black Swiss background (B). Nfib/ mice displayed enlarged ventricles (C and
F; asterisks). Scale bars: 2 mm (F; applies to panels A to F) and 1 mm (I; applies to panels G to I).
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midline glial populations (11, 56), these data suggest that Nfia
and Nfib may cooperate in the development of these brain
regions.
Lung maturation defects in Nfib/ animals. Lung matura-
tion defects that are morphologically similar to those seen in
our Nfib/ animals were described previously for an insertion
mutation in the Nfib locus (22). While that study described the
defect as lung hypoplasia, our analysis shows that there is an
apparent increase in the amount of DNA in Nfib/ lungs
(Table 3), suggesting aberrant cell proliferation and/or apo-
ptosis during lung maturation. Increased PCNA expression at
E18.5 in Nfib/ versus WT lungs is also consistent with in-
creased cell proliferation (Table 4). Prenatal lung maturation
proceeds through a series of morphologically and biochemi-
cally defined stages (10) from budding (approximately E9.5),
initial branching morphogenesis and expansion (pseudoglan-
dular, approximately E9.5 to E16.5), continued branching of
the distal epithelium and mesenchyme (canalicular; approxi-
mately E16.5 to E17.5), and formation of terminal saccules
with terminal differentiation of type I and type II epithelial
cells (sacculation; approximately E17.5 to P5). Final matura-
tion of the terminal sacs into alveolar ducts and sacs (alveol-
FIG. 6. Midline glial defects in Nfib/ mice. Coronal sections were labeled with an antibody against GFAP to label the midline glial
populations. IGG (D, E, J, and K; arrowheads) and MZG (D, E, J, and K; thick arrows) were absent in Nfib/ mice on both the Black Swiss
(F) and C57BL/6 (L) backgrounds. The GW was severely reduced in the Nfib/ mice (F and L; thin arrows). Panels D to F and J to L are
higher-power views of panels A to C and G to I, respectively. Scale bars, 2 mm (I; applies to panels A to C and G to I) and 200 m (L; applies
to panels D to F and J to L).
TABLE 5. Transcript levels in Nfib/ and Nfia/ brains relative
to those in WT brainsa
Gene
Relative level in:
Nfib/ brain Nfia/ brain
GFAP 0.2 	 0.1 0.1 	 0.01
Tbr2 1.2 	 0.2 1.9 	 0.1
Slit2 1.0 	 0.2 1.0 	 0.2
Robo1 0.8 	 0.3 0.8 	 0.1
Robo2 0.8 	 0.3 1.3 	 0.3
Robo3 1.2 	 0.9 1.5 	 0.6
DCC 1.1 	 0.4 1.3 	 0.1
Sem3A 1.3 	 0.6 1.5 	 0.7
Netrin 1.1 	 0.2 1.6 	 0.2
Neog 0.9 	 0.1 1.2 	 0.3
Neurop1 1.2 	 0.2 0.8 	 0.02
Neurop2 1.0 	 0.3 1.4 	 0.6
Emx1 1.0 	 0.1 0.8 	 0.02
Emx2 1.3 	 0.2 1.3 	 0.2
L1 1.1 	 0.4 0.9 	 0.1
Sek 1.2 	 0.5 1.5 	 0.2
Nuk 1.2 	 0.3 1.3 	 0.5
a Transcript levels were measured and expressed as described for Table 4.
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ization) occurs postnatally from approximately P5 to P30 (47,
65). The reduction of specific epithelial markers seen here
(Table 4), together with the lack of saccule formation, indi-
cates that the lungs in Nfib/ mice are arrested at the late-
pseudoglandular or early-canalicular stage of maturation.
Since the morbidity and mortality of premature infants are
strongly associated with a failure of lung maturation (45), these
mice may provide a useful model to investigate the later stages
of prenatal lung maturation.
Failure of late fetal lung maturation has also been seen in
mice containing targeted disruptions of the genes encoding
glucocorticoid receptor (9), transforming growth factor 3
(55), endothelial nitric oxide synthase (24), and Sp3 (5) and
other genes (66, 68, 69). The pathways linking this diverse set
of molecules to the developmental events essential for lung
maturation have not yet been determined. Given the possible
increase in cell number seen in the Nfib/ lungs (Table 3), it
is of interest that the combined loss of p21CIP and p57KIP2,
two Cdk inhibitors that mediate cell cycle arrest, results in a
maturation arrest that appears morphologically similar to that
seen with loss of Nfib (69). Thus it is possible that Nfib is
involved in either mesenchymal or epithelial cell exit from the
cell cycle and that this cell cycle arrest is essential for normal
maturation of the lung. Consistent with this model are the
observations that overexpression of NFIB and other NFI pro-
teins can suppress the oncogenic transformation of chicken
embryo fibroblasts mediated by a number of nuclear onco-
genes (52) and that rearrangement or altered expression or
both of NFIB have been associated with the overgrowth syn-
dromes of pleomorphic adenoma (17) and polycythemia vera
(29). To test this model, it will be useful in future studies to
determine whether the apparent increase in cell number in the
Nfib/ lungs is due to changes in cell proliferation, apoptosis,
or both.
Since Nfib/ mice have defects in both lung maturation and
commissural tract formation (Fig. 2 to 8), it is noteworthy that
loss of the known axon guidance receptor gene Robo1 also
causes perinatal lethality attributed to a failure of lung matu-
FIG. 7. Development of the hippocampus is severely disrupted in Nfib/ mice. Coronal 50-m vibratome sections from E17.5 (A to F) and
E15.5 (G to I) embryos were mounted and stained with hematoxylin to reveal the structural morphology of the hippocampus. Gross regionalization
of the hippocampus is evident in panel A. Note that the CA2 subfield has not yet developed by E17.5. Nfib/ mice have a complete absence of
the dentate gyrus (DG; asterisks [C and F] denote the region where the DG should have developed) and a reduction in the size of the fimbria (Fi;
A and C). (A to C) Sections of brains from mice on a mixed Black Swiss background; (D to I) brains from mice on a C57BL/6 background. Scale
bars, 200 m (C; applies to panels A to F) and 50 m (I; applies to panels G to I).
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ration (66). Robo1 is a mouse ortholog of Roundabout, which is
essential for normal midline axonal crossing in Drosophila (26).
The Robo gene family encodes receptors with homology to the
neural CAM family of cell surface adhesion molecules and
appears to regulate axon guidance in both Drosophila and mice
(49). This gene family has been implicated in regulating axon
guidance in mice and humans (27, 37, 63), but its role in lung
development is unknown (1). The expression patterns for Robo
and Slit family members during lung maturation are consistent
with a role for Robo signaling in epithelium-mesenchyme in-
teractions (19). Although we observed no decrease in overall
Robo1 expression in Nfib/ brains (Table 4), analysis of the
expression patterns of Robo1 and other signaling molecules by
in situ hybridization in Nfib/ animals might reveal regional
changes in expression related to the observed phenotypes in
brain and lung.
It will be important to determine the specific gene expres-
sion changes in Nfib/ lungs that affect maturation. However,
given the failure of lung maturation in the Nfib/ mice, it will
be essential to distinguish between changes that directly affect
the maturation process and those that simply reflect the im-
mature state of the Nfib/ lungs. For example, while we’ve
seen decreases in the expression of a number of type II and
type I epithelial markers in E18.5 Nfib/ lungs (Table 4), it is
possible these changes merely reflect lack of maturity of the
Nfib/ versus Nfib/ lungs. Since the expression levels of
several of these genes normally increase during lung matura-
tion, it is not surprising that their expression levels are reduced
in the less mature Nfib/ lungs. Thus it will be important to
determine the earliest time in development at which differ-
ences in gene expression between Nfib/ and Nfib/ lungs
occur and which of the genes affected at this time are essential
for maturation.
One known target for NFI genes in the developing lung
epithelium is SP-C. Previous studies showed that the SP-C
gene promoter is activated by NFI proteins, including NFI-B2,
and that a transgene-encoded dominant repressor (NFI-en-
grailed) inhibits the expression of SP-C in mouse lung (2, 3).
Thus SP-C is a good candidate for a direct target of Nfib in the
developing lung. However, SP-C is highly expressed only late in
lung maturation and SP-C mutant mice do not exhibit a failure
in lung maturation (18). Given the expression pattern of the
Nfib::lacZ allele (Fig. 4), it is possible that Nfib regulates both
mesenchymal target genes that are essential for the maturation
process early in lung development and also epithelial genes
that are expressed later in lung development and that are
important for physiological functioning of the lung. An impor-
tant future goal is to distinguish between these two potential
classes of Nfib target genes.
Neurological defects in Nfib/ animals. While the callosal
agenesis (Fig. 5 and 6) and loss of midline GFAP staining (Fig.
6) seen in Nfib/ animals is reminiscent of the phenotype
seen previously in Nfia/ mice (11, 56), there are clear mor-
phological differences between the two mutants. For example,
Nfib/ animals usually lack large Probst bundles, regions of
axonal overlap and swirling near the midline that are often
present in Nfia/ animals (56). Such differences imply that,
while both genes are essential for callosal formation, they may
have both shared and distinct functions in this developmental
process. Both Nfia and Nfib are expressed in the cortex (6, 56)
(data not shown), but the lack of markers specific for callosally
projecting neurons makes it difficult to assess the significance
of this cortical expression. The similar losses of midline glial
populations in Nfib/ mice (Fig. 6) and Nfia/ mice (56)
FIG. 8. Absence of the basilar pons in Nfib/ mice. Sagittal sections of E18.5 Nfib/ (A), Nfib/ (B), and Nfib/ (C) hindbrains stained
with thionin. Brains were from litters backcrossed for five generations to C57BL/6. The basilar pons (BP) is present in panels A and B but not panel
C (arrowhead). The rest of the hindbrain, including the inferior olive (IO), appears normal in the mutant, and the cerebellum (Cb) is present but
appears unfoliated in panel C. Scale bar (A), 0.5 mm (applies to all panels).
TABLE 6. Levels of the other three Nfi genes in Nfib/ lungs and
brainsa
Nfi gene
Relative level in:
Nfib/
E18.5 lungs
Nfib/
E18.5 brains
Nfia 5.1 	 2.0 2.2 	 0.6
Nfic 3.3 	 0.7 1.2 	 0.4
Nfix 2.8 	 0.6 1.3 	 0.3
a Transcript levels relative to those in WT organs were assessed by QPCR as
described for Table 4.
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suggest that both genes may cooperate in the growth and
differentiation of these midline glial cells. Given the relatively
restricted set of glial cells affected by loss of either Nfia or Nfib,
it will be of interest to determine whether simultaneous loss of
both Nfi genes produces a more severe phenotype in glial cell
development.
While both Nfia- and Nfib-deficient mice exhibit agenesis of
the corpus callosum, the Nfib-deficient mice have additional
neurological defects not reported for Nfia-deficient animals,
including severe defects in hippocampus (Fig. 7) and pons (Fig.
8) formation. Nfib had been shown previously to be expressed
in both the hippocampus and the pons (6, 16), and thus it is
possible that the defects in these regions are due to cell-
autonomous defects in cells that normally express Nfib. Nfib is
one of a small class of genes known to affect hippocampus
development, a class which includes the genes Lhx-5 (70),
Beta2/NeuroD (34), Lef-1 (15), CXCR4 (38), LRP6 (71), and
Emx-2 (46, 51) and the Reelin–Disabled-1–beta(1)-class inte-
grin pathway (14). The mechanisms by which these genes affect
the molecular pathways and cellular processes essential for
hippocampal development are beginning to be understood.
LRP6-deficient mice have generalized defects in the Wnt/beta
catenin signaling pathway because of the crucial function of
LRP6 as a Wnt signaling coreceptor (71). These mice have
severe defects in the dentate gyrus due to the decreased pro-
duction of dentate granule cells. They also have abnormalities
of the radial glial scaffolding in the forming dentate gyrus. By
examining the hippocampal primordium at early stages, the
authors showed a reduction in the number of dentate granule
cell progenitors in the dentate ventricular zone prior to the
emigration of the earliest granule neurons and precursors to
form the dentate anlage. It is possible that loss of Nfib-regu-
lated gene transcription may lead to a similar alteration of the
hippocampal primordium, with resultant severe hypoplasia of
the dentate gyrus. A more detailed analysis of early hippocam-
pus development in the Nfib/ mice should allow us to test
this model for Nfib function in the dentate gyrus.
The molecular mechanisms leading to the loss of the basilar
pons in Nfib/ mice are unknown. It may be that Nfib regu-
lates one or more signaling molecules, such as DCC or Rig-1/
Robo3, that control the migration of pontine neurons to the
midline (39). Alternatively, Nfib may interact with other tran-
scription factors that regulate pontine formation (4, 13, 33).
Distinguishing between these and other possibilities awaits
characterization of the fate of pontine neurons in Nfib/
mice. Since analysis of whole-brain RNA has failed to find
changes in the expression of some molecules known to influ-
ence axon guidance and cell migration (Table 5), determining
whether there are common Nfib target genes that mediate the
defects in callosal formation, hippocampal development, and
pons formation will require a detailed analysis of Nfib target
genes in each of these regions of the brain.
Given the severity of the neurological phenotypes seen in
the Nfib/ animals, it is perhaps surprising that a previous
study of an insertion of a lacZ translational fusion gene into
the Nfib locus found no neurological defects (22). This is de-
spite the finding that the lung maturation defects seen in our
Nfib KO animals appear morphologically similar to those seen
in animals with the Nfib insertion mutation. There are several
possible explanations for such differences. (i) With both our
Nfia/ and Nfic/ mice we showed that deletion of exon 2
results in aberrant splicing from the first to the third exons of
the genes (11, 61). We show a similar aberrant transcript from
our disrupted Nfib locus (Fig. 1C). These aberrant transcripts
do not encode functional proteins as they are missing DNA
binding and dimerization domains and as the exons are out of
frame, yielding short missense peptides. It is possible that
aberrant splicing into the still-present second exon of the in-
sertion mutant gene could generate a hypomorphic, but not
null, allele in these animals. In our Nfib mutant allele the
second exon is deleted, precluding this possibility. (ii) We
showed previously that Nfib has an alternative first exon, ex-
pressed specifically in the brain (21, 42). Splicing from this
brain-specific exon into the still present second exon of the
insertion mutant gene may be why no brain phenotype for the
insertion mutant was seen. Also, the report for the insertion
mutant failed to show any -Gal activity from the targeted
allele or to demonstrate loss of Nfib expression, making it
difficult to compare to the present study. While further studies
are needed to resolve these differences, it is clear that our
Nfib/mice have severe lung and brain phenotypes, making
them an important tool with which to study Nfib function.
NFI gene family in mouse development. Three of the four
mouse NFI genes have now been disrupted, and each mutant
has unique defects in development. Disruption of Nfia results
in callosal agenesis, perinatal lethality, hydrocephalus, reduc-
tion in the hippocampal commissure, and loss of specific mid-
line glial populations (11, 56). Some of these defects are also
present in the Nfib/ mice described here. In contrast, dis-
ruption of the Nfic gene results in postnatal defects in tooth
formation, with no observable defects in neuroanatomy and no
lethality if the diet is composed of soft food (61). Since the
Nfib/ mice do not survive postnatally, it is not possible to tell
if they have tooth defects similar to those seen in Nfic/ mice.
Since the four NFI genes encode proteins with highly homol-
ogous DNA-binding domains with similar DNA-binding spec-
ificities (40), it is possible that there are common downstream
targets for all four NFI genes. It is unclear whether the diverse
defects seen upon loss of the individual NFI genes are due to
differences in the expression patterns of the four genes, differ-
ences in downstream target specificity, differences in gene ac-
tivation or repression by specific NFI isoforms, or other fac-
tors. One feature that is common in the mutants is that the
defects are seen relatively late in fetal or postnatal develop-
ment. In Nfia/ and Nfib/ mice the first morphological
indication of differences is at E14 to E15, while for Nfic/
mice the first changes are seen at approximately P10. Thus at
least three of the four NFI genes are essential for relatively late
developmental processes in the mouse. Since the four NFI
genes are expressed in an overlapping pattern during develop-
ment (6) and since changes in NFI transcript levels are first
detected at the four-cell stage in embryogenesis (23), it will be
of interest to determine whether multiple NFI genes cooperate
at earlier stages of mouse development.
It is difficult to connect the diverse defects seen in the
Nfib/ mice, callosal agenesis, aberrant gliogenesis, hip-
pocampus and pons development, and failure of lung matura-
tion, into a simple model of Nfib function. It will be necessary
to determine the earliest stages at which gene expression
changes occur in the affected tissues in order to determine
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whether common or unique Nfib target genes are affected in
each organ. Since different NFI proteins have been found to
either activate or repress expression from the same promoter
depending on the cellular context (7, 8; reviewed in references
21 and 42), it will be important to analyze mice with mutations
in multiple NFI genes to determine whether they cooperate or
antagonize each other at earlier developmental stages. The
future identification of direct downstream targets of Nfib, to-
gether with analysis of the effects of the combined loss of Nfib
together with other genes known to affect brain and lung for-
mation, should allow us to determine the molecular mecha-
nisms through which Nfib functions in lung and brain devel-
opment.
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